Posts

Posted on

Everbridge Software Platform Selected to Support Second Consecutive Presidential Inauguration

Everbridge Software Platform Selected to Support Second Consecutive Presidential Inauguration

Everbridge Supports National Capital Region, D.C. Government and United States Park Police with Critical Event Management (CEM) Platform for Event Notifications and Emergency Alerting

BURLINGTON, Mass.–(BUSINESS WIRE)–Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced its Mass Notification system will be used to help keep Washington, D.C. area residents and visitors safe and informed in the days leading up to and during the Presidential Inauguration in Washington, D.C. on January 20, 2021. The United States Park Police (USPP), one of the oldest uniformed federal law enforcement agencies in the country, and the District of Columbia government, will once again partner to leverage the Everbridge platform to provide subscribers with safety, weather, traffic, event and emergency alerts, at a time when the ongoing COVID-19 outbreak poses new challenges for organizers and attendees.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210113005522/en/

Everbridge Selected to Support Second Consecutive Presidential Inauguration (Photo: Business Wire)

Everbridge Selected to Support Second Consecutive Presidential Inauguration (Photo: Business Wire)

Given the rising number of coronavirus cases around the country, the incoming administration plans a scaled-back Inauguration Day with a focus on pandemic safety procedures, fewer public events, and a smaller gathering on the National Mall. City officials encourage residents and visitors to sign up to receive the latest information and updates leading up to and throughout the event. Current subscribers in the Washington, D.C. area will continue to receive their regular local alerts from Everbridge and can choose to opt-in to Presidential Inauguration specific information.

This marks the second Presidential Inauguration in which D.C.-area public safety agencies utilized Everbridge to help protect residents and attendees and ensure a smooth day of activities. In 2017, USPP and D.C. Homeland Security teamed up with Everbridge to keep everyone informed throughout Inauguration week.

“We are honored to partner again with the Washington, D.C. government and the United States Park Police in their efforts to provide timely and actionable information on Inauguration Day,” said Brian Toolan, Head of Government Strategy for Everbridge. “With COVID-19 making this an Inauguration unlike any before, it remains imperative to follow the guidelines put forth by officials to make this a safe experience.”

Other large-scale deployments of Everbridge for major events include football championships, celebratory parades, Times Square New Year’s Eve celebrations and the Macy’s Thanksgiving Day Parade. Previous events also include the Pride Parade in San Francisco, Mardi Gras in New Orleans, and the March For Our Lives rally in Washington, D.C.

“The National Capital Region is responsible for promoting a safe environment for over five million residents in Virginia, Maryland, and Washington,” said Sulayman Brown, Assistant Coordinator for Fairfax County Office of Emergency Management. “NCR needs to communicate securely and effectively to our residents during both emergencies and non-emergency events. We leveraged Everbridge to quickly inform citizens across the region of impacts caused by unrest at the Capitol.”

More than 70 federal agencies rely on the Everbridge CEM platform including the General Services Administration, the Federal Communications Commission (FCC), the U.S. Nuclear Regulatory Commission, the Departments of Defense, Commerce, Energy, Interior, Justice, and Health and Human Services, the Consumer Financial Protection Bureau, the Federal Deposit Insurance Corporation, the Environmental Protection Agency, the Social Security Administration, the National Cancer Institute, and the Peace Corps.

About Everbridge

Everbridge, Inc. (NASDAQ: EVBG) is a global software company that provides enterprise software applications that automate and accelerate organizations’ operational response to critical events in order Keep People Safe and Businesses Running™. During public safety threats such as active shooter situations, terrorist attacks or severe weather conditions, as well as critical business events including IT outages, cyber-attacks or other incidents such as product recalls or supply-chain interruptions, over 5,400 global customers rely on the Company’s Critical Event Management Platform to quickly and reliably aggregate and assess threat data, locate people at risk and responders able to assist, automate the execution of pre-defined communications processes through the secure delivery to over 100 different communication devices, and track progress on executing response plans. Everbridge serves 8 of the 10 largest U.S. cities, 9 of the 10 largest U.S.-based investment banks, 47 of the 50 busiest North American airports, 9 of the 10 largest global consulting firms, 8 of the 10 largest global automakers, 9 of the 10 largest U.S.-based health care providers, and 7 of the 10 largest technology companies in the world. Everbridge is based in Boston with additional offices in 20 cities around the globe. For more information visit www.everbridge.com

Cautionary Language Concerning Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the anticipated opportunity and trends for growth in our critical communications and enterprise safety applications and our overall business, our market opportunity, our expectations regarding sales of our products, our goal to maintain market leadership and extend the markets in which we compete for customers, and anticipated impact on financial results. These forward-looking statements are made as of the date of this press release and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control. Our actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the ability of our products and services to perform as intended and meet our customers’ expectations; our ability to successfully integrate businesses and assets that we may acquire; our ability to attract new customers and retain and increase sales to existing customers; our ability to increase sales of our Mass Notification application and/or ability to increase sales of our other applications; developments in the market for targeted and contextually relevant critical communications or the associated regulatory environment; our estimates of market opportunity and forecasts of market growth may prove to be inaccurate; we have not been profitable on a consistent basis historically and may not achieve or maintain profitability in the future; the lengthy and unpredictable sales cycles for new customers; nature of our business exposes us to inherent liability risks; our ability to attract, integrate and retain qualified personnel; our ability to maintain successful relationships with our channel partners and technology partners; our ability to manage our growth effectively; our ability to respond to competitive pressures; potential liability related to privacy and security of personally identifiable information; our ability to protect our intellectual property rights, and the other risks detailed in our risk factors discussed in filings with the U.S. Securities and Exchange Commission (“SEC”), including but not limited to our Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 28, 2020. The forward-looking statements included in this press release represent our views as of the date of this press release. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

All Everbridge products are trademarks of Everbridge, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.

Everbridge:

Jim Gatta

Media Relations

[email protected]

215-290-3799

Joshua Young

Investor Relations

[email protected]

781-236-3695

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Software Mobile/Wireless White House/Federal Government Law Enforcement/Emergency Services Technology State/Local Other Policy Issues Security Homeland Security Elections/Campaigns Congressional News/Views Public Policy/Government

MEDIA:

Photo
Photo
Everbridge Selected to Support Second Consecutive Presidential Inauguration (Photo: Business Wire)
Logo
Logo
Posted on

State Street Expands Capabilities in Latin America Region

State Street Expands Capabilities in Latin America Region

Commences Onshore Brazilian Real Trading Operations to Further Bolster the Firm’s Foreign Exchange Services in Emerging Markets; Appoints Marcia Rothschild to Head of Latin America Region

BOSTON–(BUSINESS WIRE)–
State Street Corporation (NYSE:STT) today announced that its Brazilian bank has begun to offer full foreign exchange (FX) trading capabilities and sales operations. State Street previously acquired control of Natixis Brasil S.A. – Banco Múltiplo, a São Paulo-based Brazilian financial institution in 2019.

This milestone serves as an important marker for the firm’s broader expansion plans for the Latin American region, as this an opportunity to better serve both its local and global clients – as well as prospects – by bringing its market leading capabilities and unparalleled scale to LatAm.

State Street now has 13 FX sales and trading desk locations globally, and combined with its global custodial network, provides clients with the highest levels of onshore access. Through local trading desks, State Street clients have an unparalleled level of insight into the conditions and developments impacting local markets, as well as additional access to liquidity.

“Today’s announcement is the culmination of many years of diligent planning,” said Tony Bisegna, global head of multi asset class trading and research for State Street Global Markets. “Brazil – like many other Latin American countries – is an increasingly important market for institutional investors globally. State Street continues to be very well positioned to help our global clients navigate the challenges of investing in emerging markets, through our market leading foreign exchange products, as well as our award-winning research platform which combines State Street’s proprietary flow information, real-time economic indicators derived from big data, and partnerships with academics to deliver investment strategy insights to our clients.”

State Street also announced it has appointed Marcia Rothschild as head of Latin America with responsibility for leading sales and deepening relationships with clients and prospects. She joins from Vistra where she served as business development director for Vistra’s Alternatives division. Prior to working at Vistra, Rothschild held leadership positions at SS&C, Citigroup, and BNP Paribas.

“I’m very excited to be leading State Street’s expansion efforts in the Latin American region,” said Rothschild. “LatAm is a very important region for the firm, and I believe there are tremendous opportunities when you combine State Street’s global scale with the local talent we have already added. I’m confident this will allow us to continue to execute on our ambitious growth plans in the region.”

Earlier this year, State Street was ranked by Euromoney Magazine as number one provider in several Foreign Exchange services, including being ranked No. 1 in Real Money Market Share for the third consecutive year, as well as Number 1 in Research for Real Money and Customer Satisfaction. The ranking, now in its 42nd year, is the most comprehensive quantitative and qualitative annual study available on the foreign exchange markets. Click here to see the full rankings.

About State Street Corporation

State Street Corporation (NYSE: STT) is one of the world’s leading providers of financial services to institutional investors including investment servicing, investment management and investment research and trading. With $36.6 trillion in assets under custody and/or administration and $3.1 trillion* in assets under management as of September 30, 2020, State Street operates globally in more than 100 geographic markets and employs approximately 39,000 worldwide. For more information, visit State Street’s website at www.statestreet.com.

*Assets under management as of September 30, 2020 includes approximately $81 billion of assets with respect to SPDR® products for which State Street Global Advisors Funds Distributors, LLC (SSGA FD) acts solely as the marketing agent. SSGA FD and State Street Global Advisors are affiliated.

© 2021 State Street Corporation – All Rights Reserved

3402475.1.1.GBL.RTL

Brendan Paul

[email protected]

401-644-9182

KEYWORDS: Massachusetts United States South America North America Brazil

INDUSTRY KEYWORDS: Finance Consulting Banking Professional Services Other Professional Services

MEDIA:

Logo
Logo
Posted on

Quanterix Provides Operational and Preliminary Financial Highlights

Quanterix Provides Operational and Preliminary Financial Highlights

Expects Q4 2020 GAAP revenue of $24-26 million; Non-GAAP revenue of $20-22 million, up approximately 32% over prior Q4

Quanterix to present at J.P. Morgan Healthcare Conference on January 13, 2021 at 3:40 pm ET

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today provided operational and preliminary financial highlights for the fourth quarter and fiscal year ended December 31, 2020.

“While last year brought extraordinary challenges for the world, it also amplified the critical potential of our precision health strategy to address acute issues associated with the spread of COVID-19 virus and longer-term health concerns resulting from the infection,” said Kevin Hrusovsky, Chairman, Chief Executive Officer and President, Quanterix and Founder of Powering Precision Health (PPH). “Our timely pivot to address the pandemic enabled us to keep our employees safe and by year-end, deliver a robust suite of novel COVID-19 testing solutions to support the battle in 2021. Our advances in ultra-sensitive proteomics testing enable top researchers to tackle important COVID challenges and accelerate our Neurology tools strategy with vital new additions to our assay menu supporting both Alzheimer’s and COVID-19 research and diagnostics. We enter 2021 with short and long-term growth catalysts fueling our potential to scale our powering precision health strategy.”

Operational Highlights:

  • Awarded an $18.2M contract with the NIH through its RADx initiative to accelerate the continued development and scale-up of a novel SARS-CoV-2 antigen test.
  • Received FDA Emergency Use Authorizations for novel SARS-COV-2 antigen test (after year-end) and for semi-quantitative antibody test, underscoring our longstanding science-first mentality and deep dedication to the highest standards of quality and scientific rigor across our business.
  • Leveraging the unparalleled ultra-sensitivity of Simoa, enabled several leading researchers globally, including at the NIH, to begin tackling leading-edge COVID challenges, such as establishing potential for blood based anti-viral endpoints for new drug therapies and understanding the long-term complications of COVID-19.
  • Expanded our differentiated Neurology menu to include tau phosphorylated at threonine 181 (pTau-181), a highly specific biomarker for the study of Alzheimer’s disease pathology, in cerebral spinal fluid (CSF), serum and plasma as well as launched Neuro Multiplex assays associated with many neurodegenerative diseases yielding high growth potential. Our biomarker portfolio is now supporting leading Alzheimer’s programs globally.
  • Novartis’ multiple sclerosis (MS) drug KESIMPTA® (ofatumumab), which utilized Nf-L as secondary endpoint, was approved by the FDA.
  • Quanterix’ Simoa technology was highlighted in a record 443 new publications in 2020, bringing total Simoa-specific inclusions to over 1,120. Also, was invited to present at several marquis symposiums showcasing our Precision Health vision and potential to catalyze asymptomatic medicine.
  • Instrument installed base increased by 34% to 535, despite access challenges posed by COVID-19. This includes 93 HD-X placements with over 50% new installations and 84 new SR-X and SP-X placements.
  • Solidified Simoa’s technological leadership by achieving a 100x sensitivity improvement in a pilot of the digital enzyme-linked immunosorbent assay (ELISA) that powers the Company’s HD-X™ and SR-X™ Ultra-Sensitive Biomarker Detection Systems.
  • Entered into a non-exclusive royalty-bearing license agreement with Abbott Laboratories, to grant Abbott access to Quanterix’ portfolio of bead-based technology patents for use in in-vitro diagnostic (IVD) applications.
  • Realized multi-category revenue partnership with one of the largest multi-national, healthcare payor groups, with execution of multiple population surveillance studies, creating beachhead for our vision for the future of precision medicine, where early and non-invasive disease detection has the potential to transform life and healthcare costs.
  • Successfully raised $97.6 million in gross proceeds through our follow-on offering, further strengthening our balance sheet with growth capital.
  • William Geist joined Quanterix as Chief Operating Officer to help us sustain and grown our strong momentum across numerous digital biomarker platforms.

Preliminary Non-Audited Financial Highlights:

Q4 2020

  • Expects GAAP revenue of $24-26 million; Non-GAAP revenue of $20-22 million.(1)
  • Non-GAAP revenue, which excludes revenue from the RADx contract, represents an increase of approximately 32% over prior Q4, driven by growth in Consumables and Accelerator Services revenue.

Full Year 2020

  • Expects GAAP revenue of $84-86 million; Non-GAAP revenue of $67-69 million.(2)
  • Non-GAAP revenue, which excludes revenue from the RADx contract and the Abbott license agreement, represents an increase of approximately 20% over prior year, despite COVID customer activity and access challenges, driven by growth in Accelerator Services revenue.

(1) Non-GAAP revenue for Q4 excludes approximately $4 million in RADx-related revenue, which is included in GAAP revenue and subject to adjustment pending finalization of contract accounting for Q4.

(2) Non-GAAP revenue for full year excludes the approximate $4 million in Q4 RADx-related revenue noted above, plus an additional $1.9 million of RADx revenue and $11.2 million in revenue relating to the Abbott license agreement recognized in Q3, all of which is included in GAAP revenue.

The estimated unaudited financial results as of and for the fourth quarter and full fiscal year ended December 31, 2020 presented above are preliminary and are subject to completion of our quarter-end and year-end closing procedures and further financial review. This preliminary financial information has not been audited by our independent auditing firm. Our actual results may differ from these estimates as a result of the completion of our quarter-end and year-end closing procedures, review adjustments and other developments that may arise between now and the time our financial results for the fourth quarter and year are finalized.

Presentation at JP Morgan Healthcare Conference

As previously announced, Kevin Hrusovsky will give a corporate update at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 13, 2021 at 3:40 p.m., EST (12:40 p.m., PST). A live webcast of the session will be made available to attendees and public listeners at https://jpmorgan.metameetings.net/events/healthcare21/sessions/35235-quanterix-corporation/webcast?gpu_only=true&kiosk=true.

Replays of the webcasts will be available for a limited period following the conference.

Non-GAAP Financial Measures

To supplement the Company’s financial revenue presented on a GAAP basis, the Company has provided information on non-GAAP revenue. Management uses this non-GAAP measure to evaluate the Company’s operating performance in a manner that allows for meaningful period-to-period comparison and analysis of trends in its business. Management believes that this measure is important in comparing current results with prior period results and is useful to investors and financial analysts in assessing the Company’s operating performance. The non-GAAP financial information presented here should be considered in conjunction with, and not as a substitute for, the financial information presented in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures.

About Quanterix

Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts. For additional information, please visit https://www.quanterix.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this news release are based on Quanterix’ expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause Quanterix’ actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Quanterix’ filings with the U.S. Securities and Exchange Commission, including the “Risk Factors” sections contained therein. Except as required by law, Quanterix assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.

Media Contact:

PAN Communications

Staci Didner, (407) 734-7325

[email protected]

Investor Relations Contact:

Stephen Hrusovsky

(774) 278-0496

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Oncology Medical Supplies Health Infectious Diseases Cardiology Biotechnology

MEDIA:

Logo
Logo
Posted on

Boxlight’s Clevertouch Fills EdTech Needs in Colorado School District

Boxlight’s Clevertouch Fills EdTech Needs in Colorado School District

LAWRENCEVILLE, Ga.–(BUSINESS WIRE)–Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology, digital signage and software solutions, today announced a successful installation of Clevertouch IMPACT Plus™ panels in Canon City School District in Colorado, generating approximately $400,000 in revenue for Boxlight.

Canon City School District goals included moving towards interactive technology to meet students where they are and adapt to how they learn. Interactive education technology would also make the classroom environment more relevant and engaging. The school district understands that students are ‘digital nomads’ and use technology in their lives outside of school.

Canon City Schools invested in 110 Clevertouch IPACT Plus panels on mobile carts that were installed in all K-5 classrooms. The district chose the Clevertouch panels due to their compatibility with Chromebooks, the Clevershare collaboration app and the ability to use the Android system directly on the panel.

“The Clevertouch panels allowed us to adapt and become more mobile overall in the district,” said Dan Coppa, Instructional Technology Coach, Canon City School District. “Even the more resistant teachers are using the Clevertouch panels as an instructional tool every day in the classroom.”

For a full case study about the Canon City SD, please visit Boxlight or Clevertouch.

About Boxlight Corporation

Boxlight Corporation (Nasdaq: BOXL) is a leading provider of interactive technology solutions under its award-winning brands Clevertouch® and Mimio®. The Company aims to improve engagement and communication in diverse business and education environments. Boxlight develops, sells, and services its integrated solution suite including interactive displays, collaboration software, supporting accessories and professional services. For more information about the Boxlight story, visit http://www.boxlight.com and Clevertouch, http://clevertouch.com.

Forward Looking Statements

This press release may contain information about Boxlight’s view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements because of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to maintain and grow its business, variability of operating results, its development and introduction of new products and services, marketing and other business development initiatives, competition in the industry, etc. Boxlight encourages you to review other factors that may affect its future results in Boxlight’s filings with the Securities and Exchange Commission.

Media Relations

Sunshine Nance

+1 360-464-2119 x254

[email protected]

Investor Relations

Michael Pope

+1 360-464-4478

[email protected]

KEYWORDS: Georgia Colorado United States North America

INDUSTRY KEYWORDS: Primary/Secondary Education Retail Technology Software Specialty Hardware

MEDIA:

Posted on

Voya Financial Schedules Announcement of Fourth-Quarter and Full-Year 2020 Results

Voya Financial Schedules Announcement of Fourth-Quarter and Full-Year 2020 Results

NEW YORK–(BUSINESS WIRE)–
Voya Financial, Inc. (NYSE: VOYA), announced today that it will host a webcast and conference call on its financial results for the fourth-quarter and full-year 2020 on Wednesday, Feb. 10, 2021 from 10 a.m. to 11 a.m. ET.Voya will issue a press release announcing the company’s financial results for the fourth-quarter and full-year 2020 after the market closes on Tuesday, Feb. 9, 2021.

When issued, the press release, along with the company’s investor supplement and analyst presentation for the fourth-quarter and full-year 2020, will be available on the company’s investor relations website at investors.voya.com.

The conference call webcast, which will include a slide presentation, will be streamed live on the company’s investor relations website at investors.voya.com. Please access the webcast at least 15 minutes prior to the start of the conference call to download and install any necessary software. A replay of the webcast will be available at investors.voya.com starting at approximately 1 p.m. ET on Feb. 10, 2021.

About Voya Financial®

Voya Financial, Inc. (NYSE: VOYA), helps Americans plan, invest and protect their savings — to get ready to retire better. Serving the financial needs of approximately 13.8 million individual and institutional customers in the United States, Voya is a Fortune 500 company that had $7.5 billion in revenue in 2019. The company had $657 billion in total assets under management and administration as of Sept. 30, 2020. With a clear mission to make a secure financial future possible — one person, one family, one institution at a time — Voya’s vision is to be America’s Retirement Company®. Certified as a “Great Place to Work” by the Great Place to Work® Institute, Voya is equally committed to conducting business in a way that is socially, environmentally, economically and ethically responsible. Voya has been recognized as a 2020 World’s Most Admired Company by Fortune magazine; one of the 2020 World’s Most Ethical Companies® by the Ethisphere Institute; as a member of the Bloomberg Gender Equality Index; and as a “Best Place to Work for Disability Inclusion” on the Disability Equality Index by Disability:IN. For more information, visit voya.com. Follow Voya Financial on Facebook, LinkedIn and Twitter @Voya.

VOYA-IR VOYA-CF

Media Contacts:

Christopher Breslin

(212) 309-8941

[email protected]

Investor Contacts:

Michael Katz

(212) 309-8999

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Banking Professional Services Insurance Finance

MEDIA:

Logo
Logo
Posted on

Globalstar Signs Agreement With Ceres Tag, the World’s Only Direct to Satellite Livestock Smart Ear Tag

Globalstar Signs Agreement With Ceres Tag, the World’s Only Direct to Satellite Livestock Smart Ear Tag

COVINGTON, La.–(BUSINESS WIRE)–
Globalstar, Inc. (NYSE American: GSAT) (“Globalstar” or the “Company”) today announced that it has signed a commercial agreement with Ceres Tag, to supply satellite services to the livestock industry through the world’s first and only smart ear tag for traceability provenance, biosecurity, health, animal welfare, production improvement and theft reduction.

This agreement follows Ceres Tag’s recent success in winning the SVG Ventures THRIVE Challenge and their ear tag being named as the #1 Big Breakthrough Technology for Ag Change in the Next Decade by the AgJournal of Weekend Australian.

The Ceres Tag platform uses the unique capabilities of Globalstar to produce a small and light weight (just over one ounce) smart ear tag that attaches to the animal and automatically sends the data to the cloud via the Globalstar Satellite Network.

The Ceres Tag requires no infrastructure, no maintenance and has a battery capable of lasting the lifetime of an animal making it the lowest cost, scalable, plug and play option for ranchers to produce better performing animals at a greater profit.

David Smith, CEO of Ceres Tag, commented, “With over 1 billion cattle in the world and a similar number of sheep and goats, we now have a low-cost limitless way to monitor our animals. There has never been a more important time to know where your food has come from than during this pandemic.”

The unique relationship with Globalstar enables Ceres Tag to supply an automated daily recording of animals including world exclusive capabilities on pasture feed intake, which is primary to determining feed efficiency, genetic selection and managing of greenhouse gas. Traceability, biosecurity, performance, health and welfare have never been under more scrutiny than they are now.

David Kagan, CEO of Globalstar Inc., commented, “We saw an immediate match between Globalstar and Ceres Tag to deliver this unique monitoring capability to over 80% of the world’s livestock that are located in remote locations where there is no infrastructure and where you may only see the animals once or twice a year.”

Smith also commented, “Ceres Tag is quickly becoming one of the world’s most comprehensive animal monitoring companies with a wildlife and pet platform, also well developed in the pipeline and due for launch in 2022.”

Kagan added, “With this partnership, Globalstar will be one of the world’s largest providers of LEO satellite enabled IoT solutions. This partnership builds on a strategy of unlocking the full scalability of devices across several sectors. Animal monitoring is one of these areas in which we see significant growth opportunity.”

Ceres Tag will launch May 1, 2021 at the Beef Australia Exhibition in Rockhampton Queensland Australia and will be available for purchase from their online ecommerce website for delivery worldwide. Initial market focus will be Australia/New Zealand and North America.

About Ceres Tag

Ceres Tag is a privately held leading comprehensive animal monitoring company using automated direct to satellite information from their unique miniature proprietary on animal sensors. Ceres Tag is setting new standards for timely knowledge of monitoring for traceability provenance, biosecurity, health, animal welfare, supply chain production improvement, theft reduction, finance and insurance securitisation of livestock, equine, wildlife and pets for their owners and custodians.

About Globalstar, Inc.

Globalstar is a leading provider of customizable Satellite IoT Solutions for customers around the world in industries such as oil and gas, transportation, emergency management, government, maritime and outdoor recreation. A pioneer of mobile satellite voice and data services, Globalstar solutions connect people to their devices and allow businesses to streamline operations providing safety and communication and enabling mobile assets to be monitored remotely via the Globalstar Satellite Network. The Company’s Commercial IoT product portfolio includes industry-acclaimed SmartOne asset tracking products, Commercial IoT satellite transmitters and the SPOT® product line for personal safety, messaging and emergency response, all supported on SPOT My Globalstar, a robust cloud-based enhanced mapping solution. Completing the satellite product suite are Duplex satellite data modems, the innovative Sat-Fi2® Satellite Wi-Fi Hotspot, and Sat-Fi2® Remote Antenna Station with all product solutions offering a variety of data service plans. Learn more at Globalstar.com.

Public Relations / General Media Inquiries:

Jakomina Vidakovic

Email: [email protected] 

website: www.cerestag.com

Denise Davila

Email: [email protected]

Phone: +1-985-335-1538

 

KEYWORDS: Louisiana United States North America

INDUSTRY KEYWORDS: Data Management Satellite Technology Agriculture Telecommunications Mobile/Wireless Natural Resources

MEDIA:

Posted on

Ligand Receives Milestone Payment from Merck

Ligand Receives Milestone Payment from Merck

Milestone payment triggered by acceptance for review of a BLA for V114, an investigational 15-valent pneumococcal conjugate vaccine that utilizes Ligand’s CRM197 carrier protein

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported that the company will receive a $1.5 million milestone payment from Merck triggered by the U.S. Food and Drug Administration’s (FDA’s) acceptance for review of a biologics license application (BLA) for V114, an investigational 15-valent pneumococcal conjugate vaccine candidate for the prevention of pneumococcal disease in adults.

“This collaboration with Merck is one of the core assets that catalyzed our acquisition of Pfenex last October,” said John Higgins, Chief Executive Officer of Ligand. “If commercially launched, Ligand is entitled to a low-single-digit royalty on net sales of V114. The CRM197 carrier protein produced via our patent protected Protein Expression Technology platform is utilized in the V114 vaccine program.”

About Protein Expression Technology Platform

The Protein Expression Technology is a robust, validated, cost-effective and scalable platform for recombinant protein production, and is especially well-suited for complex, large-scale protein production where traditional systems are not suitable. Multiple global manufacturers have demonstrated consistent success with the platform and the technology is currently out-licensed for numerous commercial and development-stage programs. The versatility of the platform has been demonstrated in the production of enzymes, peptides, antibody derivatives and engineered non-natural proteins. Partners seek the platform as it can contribute significant value to biopharmaceutical development programs by reducing development timelines and costs for manufacturing therapeutics and vaccines. Given pharmaceutical industry trends toward large molecules with increasing structural complexities, the Protein Expression Technology is well positioned to meet these growing needs as the most comprehensive broadly available protein production platform in the industry.

About Ligand Pharmaceuticals

Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand’s business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand’s goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Ligand’s business model is based on doing what Ligand does best: drug discovery, early-stage drug development, product reformulation and partnering. Ligand partners with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate our revenue. Ligand’s OmniAb® technology platform is a patent-protected transgenic animal platform used in the discovery of fully human mono- and bispecific therapeutic antibodies. The Captisol® platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Ligand’s Protein Expression Technology® is a robust, validated, cost-effective and scalable approach to recombinant protein production, and is especially well-suited for complex, large-scale protein production that cannot be made by more traditional systems. Ab Initio™ technology and services for the design and preparation of customized antigens enable the successful discovery of therapeutic antibodies against difficult-to-access cellular targets. Ligand has established multiple alliances, licenses and other business relationships with the world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Roche, Sanofi, Janssen, Takeda, Gilead Sciences, GSK and Baxter International. For more information, please visit www.ligand.com.

Follow Ligand on Twitter @Ligand_LGND.

Forward-Looking Statements

This news release contains forward-looking statements by Ligand that involve risks and uncertainties and reflect Ligand’s judgment as of the date of this release. Words such as “plans,” “believes,” “expects,” “anticipates,” and “will,” and similar expressions, are intended to identify forward-looking statements. These forward-looking statements include: the timing and amount of milestone payments Ligand expects; the potential to receive royalties from net sales of V114, if approved by FDA; and the intellectual property protections with respect to Ligand’s technologies, including its Protein Expression Technology. Actual events or results may differ from Ligand’s expectations due to risks and uncertainties inherent in Ligand’s business, including, without limitation: the FDA may not agree with Merck’s interpretation of results from its clinical trials; the FDA may request additional data in connection with its review of the BLA; Ligand is dependent on Merck on the development and, if approved, commercialization of V114 and Merck may not generate net sales to generate royalties payable to Ligand; and other risks described in Ligand’s prior press releases and filings with the Securities and Exchange Commission available at www.sec.gov. Ligand disclaims any intent or obligation to update these forward-looking statements beyond the date of this release. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Ligand Pharmaceuticals Incorporated

Patrick O’Brien

[email protected]

(858) 550-7893

Twitter: @Ligand_LGND

LHA Investor Relations

Bruce Voss

[email protected]

(310) 691-7100

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Biotechnology FDA Infectious Diseases Health Pharmaceutical

MEDIA:

Logo
Logo
Posted on

Acadia Realty Trust Announces Tax Reporting Information for 2020 Distributions

Acadia Realty Trust Announces Tax Reporting Information for 2020 Distributions

RYE, N.Y.–(BUSINESS WIRE)–
Acadia Realty Trust (NYSE: AKR – “Acadia” or the “Company”) has determined that the Federal tax treatment for 2020 distributions to holders of its common shares of beneficial interest (CUSIP # 004239109) traded on the NYSE under the ticker symbol “AKR” is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Distribution Allocable to 2020

  

 

Record

  

Payment

  

Total

Distribution

  

 

 

Taxable

Qualified

  

Taxable

Ordinary

  

Total

Capital

  

Unrecaptured

Section 1250

Date

  

Date

  

Per Share

  

Total

  

Dividend

  

Dividend

  

Gain

  

Gain for 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12/31/2019

 

1/15/2020

 

$0.290000

 

$0.290000

 

$0.000000

 

$0.259980

 

$0.030020

 

$0.000100

3/31/2020

 

4/15/2020

 

$0.290000

 

$0.290000

 

$0.000000

 

$0.259980

 

$0.030020

 

$0.000100

The fourth quarter 2019 distribution that the Company paid on January 15, 2020, to shareholders of record as of December 31, 2019, was treated as paid in 2020 for income tax purposes. All 2020 ordinary dividends (other than qualified dividends and capital gains) are eligible for the 20% deduction generally allowable to non-corporate shareholders under Internal Revenue Code Section 199A. Shareholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of Acadia’s distributions.

Beginning with the second quarter of 2020, the Board of Trustees (“Board”) suspended distributions to its common shares and common units, which suspension the Board continued through the fourth quarter of 2020.

About Acadia Realty Trust

Acadia Realty Trust is an equity real estate investment trust focused on delivering long-term, profitable growth via its dual – core and fund – operating platforms and its disciplined, location-driven investment strategy. Acadia Realty Trust is accomplishing this goal by building a best-in-class core real estate portfolio with meaningful concentrations of assets in the nation’s most dynamic urban and street-retail corridors; making profitable opportunistic and value-add investments through its series of discretionary, institutional funds; and maintaining a strong balance sheet. For further information, please visit www.acadiarealty.com.

Safe Harbor Statement

Certain statements in this press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend” or “project,” or the negative thereof, or other variations thereon or comparable terminology. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause our actual results and financial performance to be materially different from future results and financial performance expressed or implied by such forward-looking statements, including, but not limited to: (i) economic, political and social uncertainty surrounding the COVID-19 pandemic, including (a) the effectiveness or lack of effectiveness of governmental relief in providing assistance to large and small businesses, including the Company’s tenants, that have suffered significant declines in revenues as a result of mandatory business shut-downs, “shelter-in-place” or “stay-at-home” orders and social distancing practices, as well as individuals adversely impacted by the COVID-19 pandemic, (b) the duration of any such orders or other formal recommendations for social distancing and the speed and extent to which revenues of the Company’s retail tenants recover following the lifting of any such orders or recommendations, (c) the potential impact of any such events on the obligations of the Company’s tenants to make rent and other payments or honor other commitments under existing leases, (d) to the extent we were seeking to sell properties in the near term, significantly greater uncertainty regarding our ability to do so at attractive prices, (e) the potential adverse impact on returns from development and redevelopment projects, and (f) the broader impact of the severe economic contraction and increase in unemployment that has occurred in the short term and negative consequences that will occur if these trends are not quickly reversed; (ii) the ability and willingness of the Company’s tenants (in particular its major tenants) and other third parties to satisfy their obligations under their respective contractual arrangements with the Company; (iii) macroeconomic conditions, such as a disruption of or lack of access to the capital markets; (iv) the Company’s success in implementing its business strategy and its ability to identify, underwrite, finance, consummate and integrate diversifying acquisitions and investments; (v) changes in general economic conditions or economic conditions in the markets in which the Company may, from time to time, compete, and their effect on the Company’s revenues, earnings and funding sources; (vi) increases in the Company’s borrowing costs as a result of changes in interest rates and other factors, including the potential phasing out of the London Interbank Offered Rate after 2021; (vii) the Company’s ability to pay down, refinance, restructure or extend its indebtedness as it becomes due; (viii) the Company’s investments in joint ventures and unconsolidated entities, including its lack of sole decision-making authority and its reliance on its joint venture partners’ financial condition; (ix) the Company’s ability to obtain the financial results expected from its development and redevelopment projects; (x) the ability and willingness of the Company’s tenants to renew their leases with the Company upon expiration, the Company’s ability to re-lease its properties on the same or better terms in the event of nonrenewal or in the event the Company exercises its right to replace an existing tenant, and obligations the Company may incur in connection with the replacement of an existing tenant; (xi) the Company’s liability for environmental matters; (xii) damage to the Company’s properties from catastrophic weather and other natural events, and the physical effects of climate change; (xiii) uninsured losses; (xiv) the Company’s ability and willingness to maintain its qualification as a REIT in light of economic, market, legal, tax and other considerations; (xv) information technology security breaches, including increased cybersecurity risks relating to the use of remote technology during the COVID-19 pandemic; and (xvi) the loss of key executives. The risks described above are not exhaustive and additional factors could adversely affect the Company’s business and financial performance, including the risk factors discussed under the section captioned “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, and other periodic or current reports the Company files with the SEC. Any forward-looking statements in this press release speak only as of the date hereof. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with regard thereto or change in the events, conditions or circumstances on which such forward-looking statements are based.

The Company uses, and intends to use, the Investors page of its website, which can be found at www.acadiarealty.com, as a means of disclosing material nonpublic information and of complying with its disclosure obligations under Regulation FD, including, without limitation, through the posting of investor presentations that may include material nonpublic information. Accordingly, investors should monitor the Investors page, in addition to following the Company’s press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, the website is not incorporated by reference into, and is not a part of, this document.

Sunny Holcomb

(914) 288-8100

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Residential Building & Real Estate Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Logo
Logo
Posted on

NETSCOUT to Report Q3 FY’21 Financial Results on January 28th

NETSCOUT to Report Q3 FY’21 Financial Results on January 28th

WESTFORD, Mass.–(BUSINESS WIRE)–NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT) plans to announce its third-quarter fiscal year 2021 financial results for the period ended December 31, 2020 on Thursday, January 28, 2021 at approximately 7:30 a.m. ET. NETSCOUT will host a corresponding conference call and live webcast on the same day at 8:30 a.m. ET.

The number for the conference call is (785) 424-1667. The conference call ID is NTCTQ321. A replay of the call will be made available after 12:00 p.m. ET on January 28th for approximately one week. The number for the replay is (800) 283-8183 for U.S./Canada and (402) 220-0867 for international callers. A live webcast of the conference call will be available on the Company’s website at https://ir.netscout.com/investors/overview/default.aspx.

About NETSCOUT

NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT) assures digital business services against disruptions in availability, performance, and security. Our market and technology leadership stems from combining our patented smart data technology with smart analytics. We provide real-time, pervasive visibility, and insights customers need to accelerate and secure their digital transformation. Our approach transforms the way organizations plan, deliver, integrate, test, and deploy services and applications. Our nGenius service assurance solutions provide real-time, contextual analysis of service, network, and application performance. Arbor security solutions protect against DDoS attacks that threaten availability and advanced threats that infiltrate networks to steal critical business assets. To learn more about improving service, network, and application performance in physical or virtual data centers, or in the cloud, and how NETSCOUT’s performance and security solutions, powered by service intelligence can help you move forward with confidence, visit www.netscout.com or follow @NETSCOUT and @ArborNetworks on Twitter, Facebook, or LinkedIn.

©2021 NETSCOUT SYSTEMS, INC. All rights reserved. NETSCOUT and the NETSCOUT logo are registered trademarks of NETSCOUT SYSTEMS, INC. and/or its subsidiaries and/or affiliates in the USA and/or other countries.

Investors

Anthony Piazza

Vice President, Corporate Finance

978-614-4286

[email protected]

Media

Maribel Lopez

Manager, Marketing & Corporate Communications

781-362-4330

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Data Management Security Technology Telecommunications Software Networks Internet

MEDIA:

Logo
Logo
Posted on

Cryptostar Corp. Signs Non-Binding Letter of Intent to Acquire Latest Generation GPU Miners with Total Hashrate of 85,680 MH/s

Canada NewsWire

TSXV: CSTR

TORONTO, Jan. 13, 2021 /CNW/ – CryptoStar Corp. (TSXV: CSTR) (“CryptoStar” or the “Company“), a cryptocurrency mining and data centre operator, is pleased to announce it has signed a non-binding letter of intent (“LOI“) with a Hong Kong based company (the “Vendor“) effective January 12, 2021 to acquire GPU miners in exchange for common shares of CryptoStar (the “Transaction“).

Highlights of the proposed Transaction:

  • Under the terms of the LOI, it is anticipated that CryptoStar and the Vendor will enter into a binding agreement (the “Definitive Agreement“) pursuant to which the Vendor will deliver GPU miners (containing the latest generation GeForce RTX 3000 Series GPU cards), capable of a combined minimum total Hashrate of 85,680 MH/s.
  • The deployment of 85,680 MH/s of Hashrate using the latest generation GPU miners is expected to contribute 142.80 ETH or USD$145,473.22 per month in self-mining revenue for CryptoStar. CryptoStar plans to continue to expand its self-mining inventory of mining hardware. (Source: https://www.cryptocompare.com/mining/calculator/eth. Mining metrics are calculated based on a network hash rate of 351,248 GH/s and using the ETH – USD exchange rate of 1 ETH = $1,018.72 updated at 2021-01-13 00:27:05 UTC).
  • GPU miners are capable of mining cryptocurrencies like Ethereum’s ether (ETH), Ethereum Classic (ETC), Zcash (ZEC), Monero (XMR) and many others.
  • The agreed upon aggregate consideration under the proposed Transaction will be satisfied by the issuance of 20,000,000 common shares of CryptoStar at a deemed value of C$0.10 per Share (which includes finder’s fees of 1,132,075 common shares) subject to acceptance by the TSX Venture Exchange (the “TSXV“).
  • Upon entering into the Definitive Agreement, it is anticipated that the GPU miners will be delivered to CryptoStar’s data centres within 14 days.

David Jellins, President and Chief Executive Officer of CryptoStar states, “We are delighted that the Vendor has selected CryptoStar as its preferred client for the supply of this highly sought-after GPU mining equipment. We are looking forward to self-mining on a larger scale and we anticipate that this will be the beginning of a long term and mutually beneficial relationship.”

Completion of the proposed Transaction is subject to TSXV approval.

About CryptoStar Corp.:

CryptoStar has cryptocurrency mining operations with data centres located in the U.S.A. and Canada. CryptoStar is currently dedicated to becoming one of the lowest cost cryptocurrency producers in North America and a major supplier of GPU and ASIC miners worldwide.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

Forward-Looking Statements

This news release contains forward-looking statements. Forward-looking statements can be identified by the use of words such as, “expects”, “is expected”, “anticipates”, “intends”, “believes”, or variations of such words and phrases or state that certain actions, events or results “may” or “will” be taken, occur or be achieved. Forward-looking statements include those relating to completion of the Transaction including approval of the TSXV thereof, the payment of a finder’s fee, entering into the Definitive Agreement and the terms thereof, the time to deliver of the GPU miners, the expected revenue generating capabilities of the GPU miners and CryptoStar’s plans to continue its self-mining inventory of mining hardware. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances. Actual results, performance or achievement could differ materially from that expressed in, or implied by, any forward-looking statements in this press release, and, accordingly, you should not place undue reliance on any such forward-looking statements and they are not guarantees of future results. Forward-looking statements involve significant risks, assumptions, uncertainties and other factors that may cause actual future results or anticipated events to differ materially from those expressed or implied in any forward looking statements. Except as required by law, CryptoStar undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE CryptoStar Corp.